ART signs GE

Article

GE Medical Systems has agreed to distribute a preclinical optical molecular imaging system made by Advanced Research Technologies. The deal grants GE exclusive worldwide rights to distribute the system, called SAMITM, which is designed for use in the R&D

GE Medical Systems has agreed to distribute a preclinical optical molecular imaging system made by Advanced Research Technologies. The deal grants GE exclusive worldwide rights to distribute the system, called SAMITM, which is designed for use in the R&D of therapeutic and diagnostic drugs. The system is an optical fluorescence molecular imaging device designed to help pharmaceutical companies and research laboratories better understand disease and shorten the development cycle for new drugs. The technology is based on ART's proprietary time domain optical imaging technology, which noninvasively images tissue to reveal the biological distribution and concentration of fluorescence-labeled markers. GE holds an equity stake in the firm and is advising staff there on the development of clinical products based on the optical technology (SCAN 11/6/02).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
New Mammography Research Examines Impact of High-Resolution DBT
Can Radioligand Therapy Have an Impact for Women with Breast Cancer?
Emerging Concepts in CT-Guided Treatment of Coronary Artery Disease
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.